Brief: Precipio CEO Provides Update Letter To Shareholders

Precipio

17/06/2019 17:08

Precipio Inc  PRPO.O :
    * PRECIPIO CEO PROVIDES UPDATE LETTER TO SHAREHOLDERS
    * PRECIPIO INC - ADDRESSES BUSINESS ACTIVITIES SURROUNDING
NEW
PRODUCTS, IV-CELL AND HEMESCREEN
    * PRECIPIO INC -  BOTH IV-CELL AND HEMESCREEN HAVE PATENTS
PENDING.
    * PRECIPIO INC - INTRODUCING THE TWO PRODUCTS BY LARGE
COMPANIES
CO IS WORKING WITH, "ALWAYS TAKES LONGER THAN WE HOPE FOR"
    * PRECIPIO INC - UNDERESTIMATED LENGTH OF TIME TO COMPLETE
FORMAL
INDEPENDENT THIRD-PARTY VALIDATION STUDIES AND CUSTOMER IN-HOUSE
REVIEWS.
    * PRECIPIO INC -  IV-CELL VALIDATION STUDIES ARE PROJECTED
TO BE
COMPLETE BY LATE Q3
    * PRECIPIO, ON IV-CELL VALIDATION STUDIES, SAYS ALL OUTSIDE
TESTING RESULTS RECEIVED SO FAR HAVE SUCCESSFULLY REPLICATED
INTERNAL DATA
    * PRECIPIO INC - THERE ARE NO PLANS TO EXECUTE AN EQUITY
RAISE.
    * PRECIPIO INC - "WHEN WE HAVE MATERIAL NEWS REGARDING
BUSINESS WE
SHARE IT"

Source text for Eikon:  ID:nGNX82lZQb 
Further company coverage:  PRPO.O